Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.

Cancer Chemother Pharmacol · 2018 · PMC5754426 · PMID 29177954

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, the Kaplan–Meier curve showed a clear trend towards improved TTP, and there was a trend towards prolonged DoR, in patients carrying the 1199A variant allele versus patients with the homozygous G/G genotype.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.